Filer Snapshot

Rapport Therapeutics, Inc. SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0002012593.

Entity Type

Company

Total Filings

188

Latest Filing

23 Apr 2026

Industry

Pharmaceutical Preparations

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.

Create free account to save and revisit this page

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

  • Use the filings table to verify the newest submission, form type, and report period.
  • Open the deeper context page only when this filer actually has insider or ownership signal.
Go to latest filings table Open insider trading context
Source: SEC filing ARS

ARS filed on 23 Apr 2026 for CIK 0002012593.

View Source Filing
Symbol
RAPP on Nasdaq
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
99 High Street, Suite 2100, Boston, MA, 02110
State of incorporation
DE
Fiscal year end
31 December

Quick Takeaways

  • Rapport Therapeutics, Inc. is an SEC filer tracked under CIK 0002012593.
  • 188 filings are listed on this profile.
  • Common form coverage includes ARS, DEFA14A, DEF 14A and more.

What Changed

  • Latest filing: ARS filed on 23 Apr 2026.
  • Report period: 31 Dec 2025.

Why This Matters

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Source Evidence

Source: SEC filing ARS

ARS filed on 23 Apr 2026 for CIK 0002012593.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed ARS can change the filing history, ownership context, or next research path for Rapport Therapeutics, Inc..

Latest source-backed update
ARS filed 23 Apr 2026
Why come back
Revisit after a new SEC filing appears to compare the updated record with prior filings.
  • Latest filing on record: ARS filed 23 Apr 2026.
  • Save this filer if you want a stable place to return after the next filing cycle.
  • Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Jump to save and follow actions Open latest filings table

Latest update

What changed recently for Rapport Therapeutics, Inc.

New fact period available

Latest financial period: Q4 2025. Open the source-backed page to inspect the fresh filing or facts context.

Update date

10 Mar 2026

Page type

Company facts

Latest period

Q4 2025

SEC-backed company facts were refreshed from filings filed on 10 Mar 2026.

Open company facts Browse recent public updates

Benchmark Context

Benchmark context for this company

Rapport Therapeutics, Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest financial period: Q4 2025. That gives you a fresh baseline before you compare this company with peers.

  • Latest company facts filing date: 10 Mar 2026.
  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Open company facts Browse metric rankings

Filer Overview

Rapport Therapeutics, Inc. has filed 188 SEC EDGAR filings since 27 Mar 2024. Common forms include ARS, DEFA14A, DEF 14A, 4 and more.

Pharmaceutical Preparations Insider transactions Latest 13F filings

Latest Filings

Recent SEC filings for Rapport Therapeutics, Inc. with direct links to document and filing folders.

Form type Document Filing Description Filing date Reporting date File number(s)
ARS Open ARS document View SEC filing for ARS ARS 23 Apr 2026 31 Dec 2025 001-42121
DEFA14A Open DEFA14A document View SEC filing for DEFA14A DEFA14A 23 Apr 2026 001-42121
DEF 14A Open DEF 14A document | Open XBRL data View SEC filing for DEF 14A DEF 14A 23 Apr 2026 10 Jun 2026 001-42121
4 Open 4 document View SEC filing for 4 4 21 Apr 2026 17 Apr 2026
4 Open 4 document View SEC filing for 4 4 21 Apr 2026 17 Apr 2026
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 21 Apr 2026 21 Apr 2026 001-42121
144 Open 144 document View SEC filing for 144 17 Apr 2026 001-42121
144 Open 144 document View SEC filing for 144 17 Apr 2026 001-42121
4 Open 4 document View SEC filing for 4 4 14 Apr 2026 10 Apr 2026
144 Open 144 document View SEC filing for 144 13 Apr 2026 001-42121
144 Open 144 document View SEC filing for 144 10 Apr 2026 001-42121
4 Open 4 document View SEC filing for 4 4 09 Apr 2026 08 Apr 2026
144 Open 144 document View SEC filing for 144 08 Apr 2026 001-42121
4 Open 4 document View SEC filing for 4 4 31 Mar 2026 30 Mar 2026
144 Open 144 document View SEC filing for 144 30 Mar 2026 001-42121
4 Open 4 document View SEC filing for 4 4 26 Mar 2026 25 Mar 2026
144 Open 144 document View SEC filing for 144 25 Mar 2026 001-42121
S-3ASR Open S-3ASR document | Open XBRL data View SEC filing for S-3ASR S-3ASR 10 Mar 2026 333-294170
S-8 Open S-8 document | Open XBRL data View SEC filing for S-8 S-8 10 Mar 2026 333-294169
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K 10-K 10 Mar 2026 31 Dec 2025 001-42121
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 10 Mar 2026 10 Mar 2026 001-42121
4 Open 4 document View SEC filing for 4 4 09 Mar 2026 05 Mar 2026
144 Open 144 document View SEC filing for 144 05 Mar 2026 001-42121
4 Open 4 document View SEC filing for 4 4 19 Feb 2026 18 Feb 2026
4 Open 4 document View SEC filing for 4 4 19 Feb 2026 17 Feb 2026
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 17 Feb 2026 005-94532
4 Open 4 document View SEC filing for 4 4 04 Feb 2026 02 Feb 2026
4 Open 4 document View SEC filing for 4 4 04 Feb 2026 02 Feb 2026
4 Open 4 document View SEC filing for 4 4 04 Feb 2026 02 Feb 2026
4 Open 4 document View SEC filing for 4 4 04 Feb 2026 02 Feb 2026
4 Open 4 document View SEC filing for 4 4 04 Feb 2026 02 Feb 2026
4 Open 4 document View SEC filing for 4 4 04 Feb 2026 02 Feb 2026
4 Open 4 document View SEC filing for 4 4 22 Jan 2026 20 Jan 2026
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 21 Jan 2026 005-94532
4 Open 4 document View SEC filing for 4 4 16 Jan 2026 15 Jan 2026
144 Open 144 document View SEC filing for 144 15 Jan 2026 001-42121
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 07 Jan 2026 07 Jan 2026 001-42121
424B5 Open 424B5 document View SEC filing for 424B5 424B5 07 Jan 2026 333-288444
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 07 Jan 2026 07 Jan 2026 001-42121
4 Open 4 document View SEC filing for 4 4 05 Jan 2026 31 Dec 2025
4 Open 4 document View SEC filing for 4 4 05 Jan 2026 31 Dec 2025
144 Open 144 document View SEC filing for 144 02 Jan 2026 001-42121
144 Open 144 document View SEC filing for 144 02 Jan 2026 001-42121
4 Open 4 document View SEC filing for 4 4 18 Dec 2025 17 Dec 2025
144 Open 144 document View SEC filing for 144 17 Dec 2025 001-42121
144 Open 144 document View SEC filing for 144 17 Dec 2025 001-42121
4 Open 4 document View SEC filing for 4 4 16 Dec 2025 15 Dec 2025
4 Open 4 document View SEC filing for 4 4 01 Dec 2025 26 Nov 2025
4 Open 4 document View SEC filing for 4 4 18 Nov 2025 17 Nov 2025
4 Open 4 document View SEC filing for 4 4 18 Nov 2025 17 Nov 2025
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 Nov 2025 005-94532
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 06 Nov 2025 30 Sep 2025 001-42121
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 06 Nov 2025 06 Nov 2025 001-42121
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 22 Oct 2025 005-94532
4 Open 4 document View SEC filing for 4 4 16 Oct 2025 15 Oct 2025
4 Open 4 document View SEC filing for 4 4 16 Oct 2025 15 Oct 2025
144 Open 144 document View SEC filing for 144 15 Oct 2025 001-42121
4 Open 4 document View SEC filing for 4 4 19 Sep 2025 17 Sep 2025
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 18 Sep 2025 005-94532
144 Open 144 document View SEC filing for 144 17 Sep 2025 001-42121
144 Open 144 document View SEC filing for 144 17 Sep 2025 001-42121
4 Open 4 document View SEC filing for 4 4 17 Sep 2025 15 Sep 2025
4 Open 4 document View SEC filing for 4 4 15 Sep 2025 12 Sep 2025
4 Open 4 document View SEC filing for 4 4 15 Sep 2025 12 Sep 2025
4 Open 4 document View SEC filing for 4 4 11 Sep 2025 11 Sep 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 10 Sep 2025 09 Sep 2025 001-42121
424B5 Open 424B5 document View SEC filing for 424B5 424B5 10 Sep 2025 333-288444
4 Open 4 document View SEC filing for 4 4 10 Sep 2025 08 Sep 2025
424B5 Open 424B5 document View SEC filing for 424B5 424B5 08 Sep 2025 333-288444
144 Open 144 document View SEC filing for 144 08 Sep 2025 001-42121
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 08 Sep 2025 08 Sep 2025 001-42121
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 08 Sep 2025 08 Sep 2025 001-42121
4 Open 4 document View SEC filing for 4 4 18 Aug 2025 15 Aug 2025
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 07 Aug 2025 30 Jun 2025 001-42121
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 07 Aug 2025 07 Aug 2025 001-42121
4 Open 4 document View SEC filing for 4 4 16 Jul 2025 15 Jul 2025
EFFECT Open EFFECT document View SEC filing for EFFECT 09 Jul 2025 333-288445
EFFECT Open EFFECT document View SEC filing for EFFECT 09 Jul 2025 333-288444
CORRESP Open CORRESP document View SEC filing for CORRESP 07 Jul 2025
CORRESP Open CORRESP document View SEC filing for CORRESP 07 Jul 2025
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 07 Jul 2025 333-288445
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 07 Jul 2025 333-288444
S-3 Open S-3 document View SEC filing for S-3 S-3 01 Jul 2025 333-288445
S-3 Open S-3 document View SEC filing for S-3 S-3 01 Jul 2025 333-288444
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 18 Jun 2025 17 Jun 2025 001-42121
4 Open 4 document View SEC filing for 4 4 18 Jun 2025 17 Jun 2025
4 Open 4 document View SEC filing for 4 4 18 Jun 2025 17 Jun 2025
4 Open 4 document View SEC filing for 4 4 18 Jun 2025 17 Jun 2025
4 Open 4 document View SEC filing for 4 4 18 Jun 2025 17 Jun 2025
4 Open 4 document View SEC filing for 4 4 18 Jun 2025 17 Jun 2025
4 Open 4 document View SEC filing for 4 4 18 Jun 2025 17 Jun 2025
4 Open 4 document View SEC filing for 4 4 18 Jun 2025 17 Jun 2025
4 Open 4 document View SEC filing for 4 4 18 Jun 2025 16 Jun 2025
4 Open 4 document View SEC filing for 4 4 18 Jun 2025 17 Jun 2025
144 Open 144 document View SEC filing for 144 16 Jun 2025 001-42121
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 02 Jun 2025 02 Jun 2025 001-42121
4 Open 4 document View SEC filing for 4 4 19 May 2025 15 May 2025
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 08 May 2025 31 Mar 2025 001-42121
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 08 May 2025 08 May 2025 001-42121
ARS Open ARS document View SEC filing for ARS ARS 24 Apr 2025 31 Dec 2024 001-42121
DEFA14A Open DEFA14A document View SEC filing for DEFA14A DEFA14A 24 Apr 2025 001-42121
DEF 14A Open DEF 14A document | Open XBRL data View SEC filing for DEF 14A DEF 14A 24 Apr 2025 17 Jun 2025 001-42121
4 Open 4 document View SEC filing for 4 4 16 Apr 2025 15 Apr 2025
4 Open 4 document View SEC filing for 4 4 03 Apr 2025 01 Apr 2025
4 Open 4 document View SEC filing for 4 4 17 Mar 2025 14 Mar 2025
144 Open 144 document View SEC filing for 144 14 Mar 2025 001-42121
4 Open 4 document View SEC filing for 4 4 13 Mar 2025 12 Mar 2025
4 Open 4 document View SEC filing for 4 4 13 Mar 2025 12 Mar 2025
S-8 Open S-8 document | Open XBRL data View SEC filing for S-8 S-8 11 Mar 2025 333-285697
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K 10-K 11 Mar 2025 31 Dec 2024 001-42121
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 11 Mar 2025 11 Mar 2025 001-42121
4 Open 4 document View SEC filing for 4 4 05 Mar 2025 03 Mar 2025
3 Open 3 document View SEC filing for 3 3 05 Mar 2025 03 Mar 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 03 Mar 2025 03 Mar 2025 001-42121
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 13 Feb 2025 005-94532
4 Open 4 document View SEC filing for 4 4 04 Feb 2025 03 Feb 2025
4 Open 4 document View SEC filing for 4 4 04 Feb 2025 03 Feb 2025
4 Open 4 document View SEC filing for 4 4 04 Feb 2025 03 Feb 2025
4 Open 4 document View SEC filing for 4 4 04 Feb 2025 03 Feb 2025
4 Open 4 document View SEC filing for 4 4 04 Feb 2025 03 Feb 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 10 Jan 2025 09 Jan 2025 001-42121
SC 13G Open SC 13G document View SEC filing for SC 13G ARCH VENTURE FUND XII, L.P. - RAPPORT THERAPEUTICS, INC. -- SCH 13G 14 Nov 2024 005-94532
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 14 Nov 2024 005-94532
SC 13G Open SC 13G document View SEC filing for SC 13G SEC SCHEDULE 13G 13 Nov 2024 005-94532
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 12 Nov 2024 005-94532
4 Open 4 document View SEC filing for 4 4 07 Nov 2024 07 Nov 2024
4 Open 4 document View SEC filing for 4 4 07 Nov 2024 07 Nov 2024
4 Open 4 document View SEC filing for 4 4 07 Nov 2024 07 Nov 2024
4 Open 4 document View SEC filing for 4 4 07 Nov 2024 07 Nov 2024
3 Open 3 document View SEC filing for 3 3 07 Nov 2024 07 Nov 2024
3 Open 3 document View SEC filing for 3 3 07 Nov 2024 07 Nov 2024
3 Open 3 document View SEC filing for 3 3 07 Nov 2024 07 Nov 2024
3 Open 3 document View SEC filing for 3 3 07 Nov 2024 07 Nov 2024
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 07 Nov 2024 30 Sep 2024 001-42121
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 07 Nov 2024 07 Nov 2024 001-42121
SC 13G Open SC 13G document View SEC filing for SC 13G 18 Oct 2024 005-94532
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 08 Aug 2024 30 Jun 2024 001-42121
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 08 Aug 2024 08 Aug 2024 001-42121
SEC STAFF LETTER Open SEC STAFF LETTER document View SEC filing for SEC STAFF LETTER 26 Jul 2024
SC 13G Open SC 13G document View SEC filing for SC 13G 10 Jul 2024 005-94532
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 03 Jul 2024 01 Jul 2024
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 24 Jun 2024 005-94532
SC 13G Open SC 13G document View SEC filing for SC 13G 21 Jun 2024 005-94532
SC 13G Open SC 13G document View SEC filing for SC 13G 20 Jun 2024 005-94532
SC 13D Open SC 13D document View SEC filing for SC 13D SC 13D 14 Jun 2024 005-94532
4 Open 4 document View SEC filing for 4 4 10 Jun 2024 10 Jun 2024
4 Open 4 document View SEC filing for 4 4 10 Jun 2024 06 Jun 2024
4 Open 4 document View SEC filing for 4 4 10 Jun 2024 06 Jun 2024
4 Open 4 document View SEC filing for 4 4 10 Jun 2024 06 Jun 2024
4 Open 4 document View SEC filing for 4 4 10 Jun 2024 06 Jun 2024
4 Open 4 document View SEC filing for 4 4 10 Jun 2024 10 Jun 2024
4 Open 4 document View SEC filing for 4 4 10 Jun 2024 06 Jun 2024
4 Open 4 document View SEC filing for 4 4 10 Jun 2024 10 Jun 2024
4 Open 4 document View SEC filing for 4 4 10 Jun 2024 06 Jun 2024
8-K Open 8-K document View SEC filing for 8-K 8-K 10 Jun 2024 06 Jun 2024 001-42121
S-8 Open S-8 document View SEC filing for S-8 S-8 07 Jun 2024 333-280058
424B4 Open 424B4 document View SEC filing for 424B4 424B4 07 Jun 2024 333-279486
EFFECT Open EFFECT document View SEC filing for EFFECT 06 Jun 2024 333-279486
3 Open 3 document View SEC filing for 3 3 06 Jun 2024 06 Jun 2024
3 Open 3 document View SEC filing for 3 3 06 Jun 2024 06 Jun 2024
3 Open 3 document View SEC filing for 3 3 06 Jun 2024 06 Jun 2024
3 Open 3 document View SEC filing for 3 3 06 Jun 2024 06 Jun 2024
3 Open 3 document View SEC filing for 3 3 06 Jun 2024 06 Jun 2024
3 Open 3 document View SEC filing for 3 3 06 Jun 2024 06 Jun 2024
3 Open 3 document View SEC filing for 3 3 06 Jun 2024 06 Jun 2024
3 Open 3 document View SEC filing for 3 3 06 Jun 2024 06 Jun 2024
3 Open 3 document View SEC filing for 3 3 06 Jun 2024 06 Jun 2024
3 Open 3 document View SEC filing for 3 3 06 Jun 2024 06 Jun 2024
3 Open 3 document View SEC filing for 3 3 06 Jun 2024 06 Jun 2024
3 Open 3 document View SEC filing for 3 3 06 Jun 2024 06 Jun 2024
3 Open 3 document View SEC filing for 3 3 06 Jun 2024 06 Jun 2024
3 Open 3 document View SEC filing for 3 3 06 Jun 2024 06 Jun 2024
CERT Open CERT document View SEC filing for CERT 06 Jun 2024 001-42121
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 04 Jun 2024 001-42121
CORRESP Open CORRESP document View SEC filing for CORRESP 04 Jun 2024
CORRESP Open CORRESP document View SEC filing for CORRESP 04 Jun 2024
CORRESP Open CORRESP document View SEC filing for CORRESP 03 Jun 2024
S-1/A Open S-1/A document View SEC filing for S-1/A S-1/A 03 Jun 2024 333-279486
CORRESP Open CORRESP document View SEC filing for CORRESP 29 May 2024
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 24 May 2024 377-07153
CORRESP Open CORRESP document View SEC filing for CORRESP 17 May 2024
S-1 Open S-1 document View SEC filing for S-1 S-1 17 May 2024 333-279486
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 13 May 2024 377-07153
SEC STAFF LETTER Open SEC STAFF LETTER document View SEC filing for SEC STAFF LETTER 03 May 2024
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 29 Apr 2024
DRS/A Open DRS/A document View SEC filing for DRS/A 29 Apr 2024 377-07153
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 24 Apr 2024 377-07153
DRS Open DRS document View SEC filing for DRS 27 Mar 2024 377-07153

About this filer

Rapport Therapeutics, Inc. files with the SEC under CIK 0002012593. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.